InvestorsHub Logo
Followers 67
Posts 3828
Boards Moderated 0
Alias Born 11/23/2014

Re: None

Tuesday, 11/21/2017 9:09:19 AM

Tuesday, November 21, 2017 9:09:19 AM

Post# of 106839
"USRM intends to take full advantage of this RMAT opportunity and join strategic partners to apply for consideration of its MyoCell product for heart failure patients."

http://us-stemcell.com/u-s-stem-cell-responds-to-fdas-regenerative-medicine-guidelines/

Everything is in my own opinion. Do what you think is right.